Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Unacylated ghrelin dose-response study during oral glucose tolerance testing in adults with type 2 diabetes
NL-OMON34644Not yet recruiting
- Start
- Oct 2010
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Trial of unacylated ghrelin in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by none. Primary endpoint: Change in glucose levels. Planned start Oct 2010; status: not yet recruiting.
02
Drugs
unacylated ghrelin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON34644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34644.